Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP477038.RABS1zJG4fMFCnbKhpeTQONUtu74yQOsi4C4LUvX6qVgA130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477038.RABS1zJG4fMFCnbKhpeTQONUtu74yQOsi4C4LUvX6qVgA130_provenance.
• NP731496.RAVbcxEbvbJs0p41BAaEy12EjMAdqLWvsKwjvTUH2nZuY130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731496.RAVbcxEbvbJs0p41BAaEy12EjMAdqLWvsKwjvTUH2nZuY130_provenance.
• assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP272550.RAihkrPx_oTbZLWcQ3JsnWBYeGacQTifBkzW7PoMWL8mI130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272550.RAihkrPx_oTbZLWcQ3JsnWBYeGacQTifBkzW7PoMWL8mI130_provenance.
• NP926017.RAdbGhfJqiS9LZSp5sQP_kSyStYDphSn7ciVzJkeWGTEA130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926017.RAdbGhfJqiS9LZSp5sQP_kSyStYDphSn7ciVzJkeWGTEA130_provenance.
• NP926019.RAekSDvHqMYLEHAakQIcqXM16elGYZ921BNkQbVLxgPWg130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926019.RAekSDvHqMYLEHAakQIcqXM16elGYZ921BNkQbVLxgPWg130_provenance.
• NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_provenance.
• NP926026.RAFnbFOkGV06HXS6T5HVDKwB7kRoB_HC4MvGGzrUQHwc8130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926026.RAFnbFOkGV06HXS6T5HVDKwB7kRoB_HC4MvGGzrUQHwc8130_provenance.
• NP926027.RAHdnEjfBZx0ttw_qypzgqtDzzdHdPmZ_DJo7GTXnCa1s130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926027.RAHdnEjfBZx0ttw_qypzgqtDzzdHdPmZ_DJo7GTXnCa1s130_provenance.
• NP926028.RAI977vLM2aKNf007gkqZyVBBKnhWpDSkg96MZUOVUYeQ130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926028.RAI977vLM2aKNf007gkqZyVBBKnhWpDSkg96MZUOVUYeQ130_provenance.
• NP926020.RA2PjY3jAB40UXUJz4puIT_2BsQrMnE08mN-y8OGOpFAA130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926020.RA2PjY3jAB40UXUJz4puIT_2BsQrMnE08mN-y8OGOpFAA130_provenance.
• NP926021.RA47C2jzK_Y_NiHOxmgBsji-KP9e7GKTiRUhy5r7KsbGE130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926021.RA47C2jzK_Y_NiHOxmgBsji-KP9e7GKTiRUhy5r7KsbGE130_provenance.
• NP926023.RA2SXjqSwXCVaf9TCcBJ-GPSTNTEm38SVpe5bFshPImNA130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926023.RA2SXjqSwXCVaf9TCcBJ-GPSTNTEm38SVpe5bFshPImNA130_provenance.
• NP926025.RAyNrAFpznHVyxfQtHTvYyIh1i_pyBE3tnz1nGIFvlSfM130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926025.RAyNrAFpznHVyxfQtHTvYyIh1i_pyBE3tnz1nGIFvlSfM130_provenance.